COMPANIES COVERED
Takeda Pharmaceutical Company Ltd.Download FREE Report Sample
Download Free sampleInsomnia Therapeutics Drugs Market contains market size and forecasts of Insomnia Therapeutics Drugs in Global, including the following market information:
Global Insomnia Therapeutics Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Insomnia Therapeutics Drugs market was valued at 3006.2 million in 2021 and is projected to reach US$ 3764 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Benzodiazepines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Insomnia Therapeutics Drugs include Takeda Pharmaceutical Company Ltd., Vanda Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sumitomo Dainippon Pharma Co., Ltd, Sanofi and Paratek Pharmaceuticals Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Insomnia Therapeutics Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insomnia Therapeutics Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Insomnia Therapeutics Drugs Market Segment Percentages, by Type, 2021 (%)
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
Global Insomnia Therapeutics Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Insomnia Therapeutics Drugs Market Segment Percentages, by Application, 2021 (%)
Prescription
Over-the-Counter (OTC)
Global Insomnia Therapeutics Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Insomnia Therapeutics Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Insomnia Therapeutics Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Insomnia Therapeutics Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy